Cardax (QB) Stock Price - CDXI

0.00 (0.0%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cardax Inc (QB) CDXI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 6.00 0.00 0.00 0.00 6.00 16:30:24
Bid Price Ask Price Spread Spread % News
3.88 6.25 2.37 37.92% 1 -
Stock Trades Traded Volume Average Volume 52 Week Range
1 8 2,536 0.032 - 6.45
Last Trade Time Type Quantity Stock Price Currency
12:20:37 8 $ 6.00 USD

Cardax (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.13M 687.56k $ -4.26M - - 277.65k
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
12.00 $ - 0.00% - -

more financials information »

Cardax (QB) News

Date Time Source News Article
3/30/202007:49Edgar (US Regulatory)Annual Report (10-k)
3/20/202017:08Edgar (US Regulatory)Current Report Filing (8-k)

Latest CDXI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CDXI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.
1 Month5.8756.255.756.013820.1252.13%
3 Months0.0556.450.045050.56656083,7865.9510,809.09%
6 Months0.0896.450.0320.080523640,3085.916,641.57%
1 Year0.1756.450.0320.102537336,7465.833,328.57%
3 Years0.226.450.0320.205650147,0355.782,627.27%
5 Years0.1156.450.030.190951748,6325.895,117.39%

Cardax (QB) Description

Cardax is a biopharmaceutical company engaged in the development and commercialization of dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. Cardax's product platform consists of a commercially available dietary supplement, ZanthoSyn, and pharmaceutical candidates, CDX-101 and CDX-301, which are in pre-clinical development for cardiovascular and macular disorders. The safety and efficacy of the Company's products have not been directly evaluated in clinical trials or confirmed by the FDA.
Your Recent History
Cardax (QB..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200331 01:26:34